Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design

Yuan-Ping Pang, Anuradha Vummenthala, Rajesh K. Mishra et al. · 2009

Read Potent New Small-Molecule Inhibitor of Botulinum Neurotoxin Serotype A Endopeptidase Developed by Synthesis-Based Computer-Aided Molecular Design by Yuan-Ping Pang, Anuradha Vummenthala, Rajesh K. Mishra et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0007730.txt.

Description

Yuan-Ping Pang and co-authors published a study in PLOS ONE in 2009. It reports a new drug candidate against botulinum neurotoxin serotype A. That toxin causes botulism, a life-threatening paralysis. Current antibody treatments can only catch toxin still outside nerve cells.

Once the toxin slips inside, antibodies cannot reach it. The active part is an enzyme that cuts key proteins. The team used computer-aided design, then built the molecule they designed. The result is a potent small-molecule blocker of that enzyme. Such a drug could treat poisoning after exposure, not just prevent it.

Catalog record

CREATORYuan-Ping Pang, Anuradha Vummenthala, Rajesh K. Mishra et al.
YEAR2009
COLLECTIONPAPERS
FORMATTXT
FILE SIZE94 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0007730

Browse the full library · About the Tower of Babel